At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. 

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease.

Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead.

As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease.

To learn more please visit www.hookipapharma.com. 


Biotechnology

Life Sciences

Pharmaceutical

HOOKIPA Pharma Inc.

Klaus Orlinger

Reinhard Kandera

Roland Bauer

Mark McKechnie

Roman Necina

Reischer Nicolas

Susan Trinker

The Research and Development team at HOOKIPA Pharma Inc. focuses on pioneering the development of advanced immunotherapies using their proprietary arenavirus platform. This team integrates expertise in virology, bioinformatics, immunology, and clinical biomarkers to design, test, and refine treatments targeting various cancers, including HPV16+ and KRAS-mutated cancers, and infectious diseases such as HBV and HIV. With roles ranging from vice presidents to junior scientists, they work collaboratively to push the boundaries of innovation, aiming to create functional cures and improve the quality of life for patients.

Research and Development

Leadership Team

Quality and Supply Chain Team

Research and Development

About

Team members

Other teams at HOOKIPA Pharma Inc.

Leadership Team

Quality and Supply Chain Team